Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €5.27 EUR
Change Today +0.02 / 0.38%
Volume 27.0K
EOSI On Other Exchanges
EN Paris
As of 11:35 AM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

eos imaging sa (EOSI) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/6/14 - €6.84
52 Week Low
01/16/15 - €4.44
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EOS IMAGING SA (EOSI)

Related News

No related news articles were found.

eos imaging sa (EOSI) Related Businessweek News

No Related Businessweek News Found

eos imaging sa (EOSI) Details

EOS Imaging SA designs, develops, and markets patented medical imaging systems used for the treatment of osteo-articular conditions. The company offers a 3D surgical planning service and patient-specific cutting guides for orthopaedic surgeries, as well as sterEOS, an associated review workstation. It also develops and markets patient-specific orthopaedic solutions for hip and knee arthroplasties, which enable surgeons to have cutting guides customized to the anatomy of patient in the operating room. EOS Imaging SA operates in France, EMEA region, North America, and Asia. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS Imaging SA was founded in 1989 and is headquartered in Paris, France.

101 Employees
Last Reported Date: 03/31/14
Founded in 1989

eos imaging sa (EOSI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: €240.1K
Vice President of Marketing
Total Annual Compensation: €112.0K
Compensation as of Fiscal Year 2013.

eos imaging sa (EOSI) Key Developments

EOS Imaging SA Reports Earnings Results for 2014; Reports Revenue Results for the First Quarter of 2015

EOS imaging SA reported earnings results for 2014. For the year, the company reported operating loss of EUR 6.15 million, net loss of EUR 5.25 million on revenue of EUR 20.06 million against operating loss of EUR 6.37 million, net loss of EUR 5.88 million on revenue of EUR 15.17 million for the same period a year ago. The company reported revenue results for the first quarter of 2015. For the quarter, the company expects total revenue of EUR 3.32 million against EUR 2.16 million for the same period a year ago.

EOS imaging’s Micro Dose Feature Highlighted at EPOS 2015

EOS imaging announced that its new Micro Dose option is being highlighted at the European Pediatric Orthopedic Society 34th Annual Meeting, April 15-18 in Marseille, France. Two of the four podium communications related with EOS benefits, will present hospital’s findings confirming that Micro Dose affords a drastic reduction in radiation exposure, and as such, should be used for follow-up imaging in adolescent patients with idiopathic scoliosis. Concurrent with the Company’s EPOS presence is the announcement that Children’s Hospital Colorado has installed an EOS system, marking the first EOS installation in the state of Colorado. U.S. News & World Report ranks Children’s Hospital Colorado seventh in the nation in pediatric orthopedics. This installation further cements EOS’ leadership position in pediatric imaging in the U.S, and demonstrates the continued groundswell of EOS adoption in the country, Micro Dose enables a further drastic step towards the ALARA (As Low As Reasonably Available) principle by bringing pediatric spine follow up exams at a dose level equivalent to a week of natural background radiation on Earth.

EOS imaging SA Announces First Installation in the Dallas-Fort Worth Area

EOS imaging announced the installation of the first EOS system at a hospital in the Dallas-Fort Worth area. This installation marks the second medical facility in Texas to adopt low dose 2D/3D imaging achieved with the EOS system. The Company also announced its participation at the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting, taking place March 24-28 in Las Vegas, where it will launch its newly released hipEOS surgical planning software. The newly installed EOS system will serve pediatric and adult patients in the Dallas-Fort Worth area suffering from spinal deformities and degenerative spine, hip and knee conditions. In addition to the adoption of the EOS system in Texas, EOS imaging has a robust agenda at AAOS 2015, where the company will exhibit and host an educational symposium to support the official launch of hipEOS in the U.S. AAOS. The EOS® system provides full-body stereo-radiographic images of patients in functional positions, in both 2D and 3D. EOS exams require a radiation dose 50% to 85% less than Digital Radiology and 95% less than basic CT scans. The new EOS Micro Dose option, recently cleared by the Food and Drug Administration, allows a further drastic step towards the ALARA (As Low As Reasonably Available) principle by bringing pediatric spine follow up exams at a dose level equivalent to a week of natural background radiation on Earth.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EOSI:FP €5.27 EUR +0.02

EOSI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EOSI.
View Industry Companies

Industry Analysis


Industry Average

Valuation EOSI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.1x
Price/Book 3.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EOS IMAGING SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at